The HBV siRNA, ALG-125755, demonstrates a favourable nonclinical profile and significant and durable hepatitis B surface antigen reductions in the AAV-HBV mouse efficacy model

Authors :: Megan Fitzgerald
Kusum Gupta
Kha Le
Sucheta Mukherjee
Jin Hong
Khiem Nguyen
Alfred Chen
Vivek Rajwanshi
Caroline Williams
Meenakshi Venkatraman
Matthew McClure
Sushmita Chanda
John Fry
David Smith
Julian Symons
Lawrence Blatt
Leonid Beigelman
Tse-I Lin
Source :: Journal of Hepatology. 77:S846
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools